Ambu A/S: Vedtægter
August 30, 2019 07:55 ET
|
Ambu A/S
Opdaterede vedtægter august 2019
Vedhæftet fil
AoA August 2019
...
Ambu A/S: Kapitalforhøjelse i forbindelse med udnyttelse af udstedte warrants
August 30, 2019 07:47 ET
|
Ambu A/S
Ambu A/S udstedte i december 2013 2.000.000 warrants og i december 2015 770.000 warrants, som hver giver ret til at tegne én B-aktie af nominelt kr. 0,50. I 2013-ordningen deltager 52 personer, og i...
Ambu A/S: Capital increase in connection with exercise of warrants issued
August 30, 2019 07:47 ET
|
Ambu A/S
In December 2013, Ambu A/S issued 2,000,000 warrants, and in December 2015 770,000 warrants, each warrant entitling the holder to subscribe for one Class B share with a nominal value of DKK 0.50. 52...
Ambu A/S: Delårsrapport for 3. kvartal 2018/19
August 22, 2019 02:00 ET
|
Ambu A/S
Ambu har i 3. kvartal realiseret en solid organisk vækst på 10 pct. og en EBIT-margin før særlige poster på 20,1 pct. Ambus pipeline af nye produkter er udvidet, de amerikanske myndigheder har...
Ambu A/S: Interim report for Q3 2018/19
August 22, 2019 02:00 ET
|
Ambu A/S
In Q3, Ambu has achieved solid organic growth of 10% and an EBIT margin before special items of 20.1%. The pipeline has been advanced, US approval of ENT scopes secured, and Ambu is on plan for future...
Ambu A/S: Ambu investerer i en 100% direkte salgs-organisation til pulmonologi i USA
August 21, 2019 19:37 ET
|
Ambu A/S
Ambu har besluttet at investere yderligere og styrke sit største marked ved at overtage salget af aScope™-produkter fra den amerikanske distributør. Dermed vil Ambu overgå fuldstændigt til direkte...
Ambu A/S: Ambu invests into a 100% direct sales organisation for pulmonology in the US
August 21, 2019 19:37 ET
|
Ambu A/S
Ambu has decided to invest further and strengthen its largest market by transitioning sales of aScope™ products from the US distributor. As a result, Ambu will move to a 100% direct sales organisation...
Ambu A/S: Gennemgang af Big Five 2020-strategien
June 17, 2019 16:05 ET
|
Ambu A/S
Ambu offentliggør tidsplan for udvidelse af produktporteføljen og investerer yderligere i salgsorganisationen. Porteføljen omfatter et nyt aScope™ 5, et nyt ureteroskop, en ny monitorplatform – der...
Ambu A/S: Review of the Big Five 2020 Strategy
June 17, 2019 16:05 ET
|
Ambu A/S
Ambu is expanding its product portfolio and commercial infrastructure. Today, we announce timelines for new aScope™ 5, a new ureteroscope, a new monitor platform that allows full HD quality and a...
Ambu A/S: Cook Medical and Ambu announce collaboration to address endoscope-related infections
May 18, 2019 16:59 ET
|
Ambu A/S
Cook Medical and Ambu A/S have agreed on terms to enter into a partnership under which Cook will distribute Ambu’s single-use, disposable duodenoscope in the U.S., following FDA clearance. The scope...